Evidence map›Paper›PMID 34978097›Full record

ArticleStatistics in medicine2022

Sample size calculation in hierarchical

Zizhong Tian, Denise Esserman, Guangyu Tong, Ondrej Blaha, James Dziura, Peter Peduzzi, Fan Li

Open access · greenAbstract read
In one paragraph

Article in Statistics in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 7 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Sample Size Requirements to Test Subgroup-Specific Treatment Effects in Cluster-Randomized Trials.Prevention science : the official journal of the Society for Prevention Research · 2024
    Article
  6. Review
  7. Article
  8. Article
  9. Pragmatic clinical trial design in emergency medicine: Study considerations and design types.Academic emergency medicine : official journal of the Society for Academic Emergency Medicine · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Zizhong TianDepartment of Biostatistics, Yale University School of Public Health, New Haven, Connecticut, USA.
Denise EssermanDepartment of Biostatistics, Yale University School of Public Health, New Haven, Connecticut, USA.ORCID 0000-0003-1326-9618
Guangyu TongDepartment of Biostatistics, Yale University School of Public Health, New Haven, Connecticut, USA.ORCID 0000-0002-7697-5029
Ondrej BlahaDepartment of Biostatistics, Yale University School of Public Health, New Haven, Connecticut, USA.
James DziuraDepartment of Biostatistics, Yale University School of Public Health, New Haven, Connecticut, USA.
Peter PeduzziDepartment of Biostatistics, Yale University School of Public Health, New Haven, Connecticut, USA.
Fan LiDepartment of Biostatistics, Yale University School of Public Health, New Haven, Connecticut, USA.ORCID 0000-0001-6183-1893
Yale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

Motivated by a suicide prevention trial with hierarchical treatment allocation (cluster-level and individual-level treatments), we address the sample size requirements for testing the treatment effects as well as their interaction. We assume a linear mixed model, within which two types of treatment effect estimands (controlled effect and marginal effect) are defined. For each null hypothesis corresponding to an estimand, we derive sample size formulas based on large-sample z-approximation, and provide finite-sample modifications based on a t-approximation. We relax the equal cluster size assumption and express the sample size formulas as functions of the mean and coefficient of variation of cluster sizes. We show that the sample size requirement for testing the controlled effect of the cluster-level treatment is more sensitive to cluster size variability than that for testing the controlled effect of the individual-level treatment; the same observation holds for testing the marginal effects. In addition, we show that the sample size for testing the interaction effect is proportional to that for testing the controlled or the marginal effect of the individual-level treatment. We conduct extensive simulations to validate the proposed sample size formulas, and find the empirical power agrees well with the predicted power for each test. Furthermore, the t-approximations often provide better control of type I error rate with a small number of clusters. Finally, we illustrate our sample size formulas to design the motivating suicide prevention factorial trial. The proposed methods are implemented in the R package H2x2Factorial.

Indexed as

Research DesignCluster AnalysisCorrelation of DataHumansLinear ModelsSample Sizecoefficient of variationcontrolled effectinteraction testlinear mixed modelmarginal effectpower analysis

Identifiers

PMID34978097
PMCPMC8962918
OpenAlexW4205872990

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.